Financials
Value Q1, 25Q2, 25Q3, 25Q1, 26 TTM Selling/general/admin expenses 63.04 M78.53 M55.87 M71.02 M — Research & development ———— — Operating income 23.9 M28.27 M38.02 M33.79 M — Non-Operating Income, Total 4.44 M27.88 M16.24 M17.96 M — Interest expense, net of interest capitalized 32.09 M33.57 M34.18 M32.63 M — Non-Operating Income, excl. Interest Expenses -27.65 M-5.69 M-17.94 M-14.67 M — Unusual income/expense ———— — Pretax income 25.25 M74.3 M43.22 M36.84 M — Equity in earnings 1.35 M3.08 M5.19 M3.05 M — Taxes 8.38 M13.92 M18.89 M11.76 M — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 16.87 M60.38 M24.32 M25.08 M — Discontinued operations ———— — Net income 16.87 M60.38 M24.32 M25.08 M — Dilution adjustment 0000 — Preferred dividends 1.39 M1.42 M1.44 M1.42 M — Diluted net income available to common stockholders 15.48 M58.95 M22.89 M23.66 M — Basic earnings per share (Basic EPS) 2.348.683.363.49 — Diluted earnings per share (Diluted EPS) 2.218.433.253.26 — Average basic shares outstanding 6.61 M6.79 M6.81 M6.78 M — Diluted shares outstanding 7 M6.99 M7.03 M7.25 M — EBITDA 48.93 M55.81 M66.69 M63.97 M — EBIT 23.9 M28.27 M38.02 M33.79 M — Cost of revenue 7.42 M19.92 M15.75 M10.19 M — Other cost of goods sold 7.44 M20.08 M15.34 M10.01 M — Depreciation & amortization (cash flow) 25.02 M27.55 M28.66 M30.18 M —